Table 2 Associations between miRNAs and clinicopathological features studied in current meta-analysis

Presence of metastasis

 GM

miR-410-3p, miR-132, miR-212, miR-802, miR-141-3p, miR-210-3p, miR-301a, miR-503, miR-543

Figure 2a

 LNM

miR-802, miR-301a, miR-503

Figure 2b

 DM

miR-132, miR-212, miR-802, miR-141-3p, miR-210-3p

Figure 2c

 BM

miR-141-3p, miR-210-3p

Figure 2d

Total Gleasone scor

 GS > 6

miR-410-3p, miR-132, miR-212, miR-203, miR-409-3p, miR-409-5p, miR-301a, miR-466, miR-503, miR-543, miR-573, miR-3622a

Figure 2e

 GS > 7

miR-132, miR-212, miR-802, miR-141-3p, miR-210-3p, miR-203, miR-409-3p, miR-409-5p, miR-301a, miR-466, miR-503, miR-543, miR-573, miR-3622a

Figure 2f

 pT stage according to TNM

miR-410-3p, miR-132, miR-212, miR-802, miR-203, miR-301a, miR-466, miR-503, miR-543, miR-573, miR-3622a

Figure 2g